SEARCH RESULTS for assignee:"BRISTOL-MYERS SQUIBB COMPANY"

Showing 1 to 20 of 100 results

Reel/Frame

Last Update:

Patent(s)

(X0) 15021102: COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS

(A1) 20160222116: COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS

(B2) 1: COMBINATION OF ANTI-LAG-3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT TUMORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15807351: BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR

(A1) 20180057600: BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR

Reel/Frame

Last Update:

Patent(s)

(X0) 15866919: MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS

(A1) 20180265572: MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS

Reel/Frame

Last Update:

Patent(s)

(X0) 14833422: TUBULYSIN ANALOGS AND METHODS OF MAKING AND USE

(A1) 20160130299: TUBULYSIN ANALOGS AND METHODS OF MAKING AND USE

(B2) 1: TUBULYSIN ANALOGS AND METHODS OF MAKING AND USE

Reel/Frame

Last Update:

Patent(s)

(X0) 15760413: FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS

(A1) 20180258158: FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS

Reel/Frame

Last Update:

Patent(s)

(X0) 15628104: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

(A1) 20170360759: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

(B2) 1: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

Reel/Frame

Last Update:

Patent(s)

(X0) 15628104: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

(A1) 20170360759: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

(B2) 1: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS

Reel/Frame

Last Update:

Patent(s)

(X0) 14950748: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

(A1) 20160090417: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

(B2) 1: CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

Reel/Frame

Last Update:

Patent(s)

(X0) 15979881: Modified FGF-21 Polypeptides and Uses Thereof

(A1) 20180243375: Modified FGF-21 Polypeptides and Uses Thereof

Reel/Frame

Last Update:

Patent(s)

(X0) 14766848: HIGH PH PROTEIN REFOLDING METHODS

(A1) 20160002287: HIGH PH PROTEIN REFOLDING METHODS

(B2) 1: HIGH PH PROTEIN REFOLDING METHODS

Reel/Frame

Last Update:

Patent(s)

(X0) 15505955: IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

(A1) 20180222901: IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

(B2) 1: IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Reel/Frame

Last Update:

Patent(s)

(X0) 15547304: CXCL11 AND SMICA AS PREDICTIVE BIOMARKERS FOR EFFICACY OF ANTI-CTLA4 IMMUNOTHERAPY

(A1) 20180246113: CXCL11 AND SMICA AS PREDICTIVE BIOMARKERS FOR EFFICACY OF ANTI-CTLA4 IMMUNOTHERAPY

Reel/Frame

Last Update:

Patent(s)

(X0) 15886118: TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR

(A1) 20180244755: TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR

Reel/Frame

Last Update:

Patent(s)

(X0) 15893102: ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES

(A1) 20180244773: ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES

Reel/Frame

Last Update:

Patent(s)

(X0) 15826196: INHIBITORS OF TYPE 2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS

(A1) 20180162926: INHIBITORS OF TYPE 2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS

Reel/Frame

Last Update:

Patent(s)

(X0) 15837034: FACTOR XIA MACROCYCLES WITH NOVEL P1 GROUPS

(A1) 20180162821: FACTOR XIA MACROCYCLES WITH NOVEL P1 GROUPS

Reel/Frame

Last Update:

Patent(s)

(X0) 15547775: ISOQUINILINE AND NAPTHALENE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION

(A1) 20180022745: ISOQUINILINE AND NAPTHALENE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION